VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ZVRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ZVRAZevra Therapeutics, Inc.
$14.44$854M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksZVRAPrice History

ZVRA logoZevra Therapeutics, Inc. (ZVRA) Stock Price History

Historical prices from 2015 to 2026

$14.44+0.47  (+3.36%)close Jul 7
Returns
1M
+19.4%
3M
+49.2%
YTD
+73.1%
1Y
+28.1%
3Y
+43.7%
5Y
+2.6%
ATH$418.40Aug 2015-96.5%
ATL$1.94May 2020pre-split
Avg Vol (50D)1.7M/ day
52-Week Range$7.16 — $14.58
LowCurrent: $14.44High

Loading 10-year price history...

ZVRA Historical Performance

1 YearTotal Return
+28.1%
Price: +28.1%
3 YearsTotal Return
+196.5%
CAGR: +43.7%
Price: +196.5%
5 YearsTotal Return
+13.8%
CAGR: +2.6%
Price: +13.8%
YTD
+73.1%

ZVRA Annual Returns

Year-by-year price performance · 2015–2026

Best+77.3%2015
Worst-84.0%2016
Up years7/12
2015+77.3%
2016-84.0%
2017+24.6%
2018-57.1%
2019-80.9%
2020+72.8%
2021-16.7%
2022-50.4%
2023+44.6%
2024+22.1%
2025+2.3%
2026+7.1%
2015 annual price return
+77.3%
2016 annual price return
-84.0%
2017 annual price return
+24.6%
2018 annual price return
-57.1%
2019 annual price return
-80.9%
2020 annual price return
+72.8%
2021 annual price return
-16.7%
2022 annual price return
-50.4%
2023 annual price return
+44.6%
2024 annual price return
+22.1%
2025 annual price return
+2.3%
2026 annual price return
+7.1%
LessMore
Alpha vs S&P 500
1Y+22.1%
3Y+13.6%
5Y-13.4%

Price returns only.

Download Historical Data

2,823 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ZVRA Stock Price Trajectory (2015–2026)

As of July 8, 2026, Zevra Therapeutics, Inc. (ZVRA) trades at $14.44, representing a +28.1% return over the past year. The stock has delivered a +13.8% total return over five years (+2.6% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $418.40 on August 14, 2015. From this peak, ZVRA has corrected -96.5%, currently trading 46% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers RARE (-9.4% 1Y), FOLD (+139.5% 1Y), and ACAD (+25.5% 1Y), ZVRA has underperformed the peer group average. Compare ZVRA vs RARE →

ZVRA Historical Price Data · from 2015

Rows 1–50 of 2,823
Date Open High Low Close Volume Change %
2026-07-0713.9614.5713.5814.441.86M+3.36%
2026-07-0614.2514.3713.7813.97988K-0.07%
2026-07-0213.9114.0413.5313.981.20M+1.23%
2026-07-0114.3114.4813.7713.811.10M-3.70%
2026-06-3014.0914.5813.9814.341.41M+2.36%
2026-06-2913.7014.1013.6114.011.54M+3.62%
2026-06-2613.2013.8213.2013.520+2.19%
2026-06-2513.1813.4912.9513.231.10M+1.15%
2026-06-2413.0013.3112.9313.08966K+0.62%
2026-06-2312.7813.1012.6413.001.34M+2.77%
2026-06-2212.9413.1912.5012.651.11M-1.94%
2026-06-1812.7813.0712.6712.901.72M+2.30%
2026-06-1712.8312.9412.5012.611.36M-0.32%
2026-06-1612.7212.7712.1812.651.25M+0.80%
2026-06-1512.7812.9912.3712.551.72M-0.79%
2026-06-1213.1313.7412.6312.651.72M-2.47%
2026-06-1113.4013.4512.6912.972.20M-3.93%
2026-06-1013.5714.2713.3813.502.59M-1.17%
2026-06-0912.5313.8012.4513.664.99M+12.99%
2026-06-0810.7112.3510.5812.093.50M+13.95%
2026-06-0511.1611.1610.3610.612.12M-5.01%
2026-06-0411.0311.4410.9511.17948K+1.92%
2026-06-0311.0311.1010.8710.961.42M+0.74%
2026-06-0211.3811.5110.8610.881.54M-5.31%
2026-06-0111.5911.9311.4111.491.77M-0.86%
2026-05-2911.5311.7411.3811.592.22M+1.67%
2026-05-2811.0611.5210.7211.403.23M+4.11%
2026-05-2710.3911.1910.3610.952.59M+6.10%
2026-05-2610.1510.3710.0610.321.82M+2.89%
2026-05-2210.4810.7210.0310.031.34M-4.39%
2026-05-2110.1710.6210.0610.492.42M+2.44%
2026-05-2010.3010.5110.1510.24994K+0.39%
2026-05-1910.4310.4310.0410.20935K-2.21%
2026-05-1811.0011.1610.3510.432.26M-5.27%
2026-05-1511.4511.4611.0011.011.70M-5.57%
2026-05-1411.2512.0611.2011.662.99M+4.86%
2026-05-1311.0111.2510.8611.12998K+0.63%
2026-05-1211.0011.1310.7711.051.10M+2.31%
2026-05-1111.3511.8610.7110.801.92M-2.96%
2026-05-0811.1911.6010.7811.132.62M+1.18%
2026-05-0710.8611.2110.2211.002.54M-2.22%
2026-05-0610.6811.2910.5711.251.90M+6.03%
2026-05-0510.1610.7310.1610.61965K+5.57%
2026-05-0410.1110.5010.0110.05908K-0.20%
2026-05-0110.1910.3410.0410.07678K-0.98%
2026-04-309.7710.319.7510.171.05M+5.17%
2026-04-299.829.889.489.67941K-2.32%
2026-04-289.9210.189.879.90623K+0.92%
2026-04-2710.0810.289.759.81742K-2.68%
2026-04-2410.1810.189.8810.08674K-0.30%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ZVRA — Frequently Asked Questions

Quick answers to the most common questions about buying ZVRA stock.

How has ZVRA stock performed recently?

ZVRA returned +28.1% over the past year, beating its 5-year annualized CAGR of +2.6%. The stock trades above its 200-day moving average, confirming the uptrend.

What is ZVRA's all-time high price?

Zevra Therapeutics, Inc. reached $418.40 on 2015-08-14. The 52-week high is $14.58. Current 1-year return of +28.1% places the stock closer to historical peaks.

Where can I download ZVRA historical price data?

This page provides ZVRA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2015-2026, downloadable in CSV format.

472 data points · sampled from 2,823